4 | SEC Filings Hub

Filing metadata

Accession number: 0001104659-22-067620
Form type: Form 4
Filer: Nabriva Therapeutics plc
CIK: CIK 1641640
Filed: Jun 02, 2022
Reporting period: May 31, 2022
Description: Insider transaction

Documents

0001104659-22-067620-index.htm

Complete submission

0001104659-22-067620.txt

directory listing

Filed by

Nabriva Therapeutics plc